EFTA02502252.pdf

From: jeffrey E. <[email protected]> Sent: Saturday, May 2, 2015 1:21 PM To: Eva Dubin Subject: Re: biaxin On Fri, May 1, 2015 at 10:04 PM, Eva Dub' rote: Levoquin or Augmentin What did Moscowitz say?? =br> Date: Fri, 1 May 2015 19:30:30 -0400 Subject: From: 'eevacation@:mail.c=m To: 101 .6 temp. =AO please note The information contained in this=communication is confidential, may be attorney-client privileged, mayconstitute inside information, and is intended only for the use of the=addressee. It is the property of JEE Unauthorized use, disclosure or=copying of this communication or any part thereof is strictly prohibite= and may be unlawful. If you have received this communication in err=r, please notify us immediately by return e-mail or by e-mail to [email protected]<=a>, and destroy this communication and all copies thereof, including=all attachments. copyright -all rights reserved please =ote EFTA_R1_01630432 EFTA02502252 The information contained in this communication is confiden=ial, may be attorney-client privileged, may constitute inside informati=n, and is intended only for the use of the addressee. It is the propert= of JEE Unauthorized use, disclosure or copying of this communica=ion or any part thereof is strictly prohibited and may be unlawful. If =ou have received this communication in error, please notify us immediat=ly by return e-mail or by e-mail to [email protected] <mailto:jeevacation@gmail=com> , and destroy this comm=nication and all copies thereof, including all attachments. copyright -=11 rights reserved 2 EFTA_R1_01630433 EFTA02502253